Cite
HARVARD Citation
Beaton, B. et al. (2023). Patients with treated indolent lymphomas immunized with BNT162b2 have reduced anti‐spike neutralizing IgG to SARS‐CoV‐2 variants, but preserved antigen‐specific T cell responses. American journal of hematology. 98 (1), pp. 131-139. [Online].